http://stroke.ahajournals.org/content/46/5/1158.extract?etoc
- Eric E. Smith, MD, MPH
+ Author Affiliations
- Correspondence to Eric E. Smith, MD, MPH, Department of Clinical Neurosciences and Hotchkiss Brain Institute, University of Calgary, Foothills Medical Centre, Room C1212, 1403 29 St NW, Calgary, Alberta T2N 2T9, Canada. E-mail eesmith@ucalgary.ca
See related article, p 1275.
In this issue of Stroke, Strbian et al1
present disappointing data on door-to-needle times (DNTs) for
tissue-type plasminogen activator (tPA) from the Safe Implementation
of Thrombolysis in Stroke (SITS) registry. Not only
was the median DNT 67 minutes long, but also there was little overall
change from 2003 to 2011 (see Figure 1 of Strbian
et al1). This means that more than half of patients were treated >60 minutes after emergency department arrival, an unacceptably
long interval.
DNTs in North America in this time period were slightly longer. In the US national Get With The Guidelines-Stroke (GWTG-Stroke)
database, median DNT from 2003 to 2009 was 78 minutes.2 In the Registry of the Canadian Stroke Network, median DNT from 2008 to 2009 was 72 minutes.3
However,
hidden within these overall disappointing data there is a glimmer of
hope. The largest volume hospitals in SITS,
treating >75 to 100 patients per year, had not
only lower times overall but also a deep and sustained drop in DNT over
time.
The earliest
joining large hospitals, treating >100 patients per year, experienced
a decrease in median DNT from just >50
minutes in 2003 to ≈30 minutes by 2008, followed by
a sustained plateau through 2011 (Figure 2 of Strbian et al1). Similar but not as dramatic decreases in DNT can be appreciated in hospitals treating 75 to 99 patients per year (Figures
1B and 2 of Strbian et al1). Statistical
modelling, adjusted for all covariates, confirmed a highly significant
interaction between calendar year and
hospital tPA volume, with the higher volume
hospitals experiencing much larger decrease over time in DNT compared
with smaller
volume hospitals (Table II in the online-only Data
Supplement of Strbian et al1).
Clearly, these
larger hospitals have, over time, learned how to shorten their DNTs.
The problem is that because there are
few large volume hospitals, most patients are
treated at the smaller volume hospitals that struggle to give tPA
rapidly. Among
the early adopters joining the registry in 2003,
81% of the patients were treated at hospitals with tPA case volumes
<75 patients
per year and 49% were treated at hospitals with tPA
case volumes <25 patients per year (Table 1 of Strbian et al1). Registry growth from 2006 to 2011 has almost exclusively consisted of new small volume hospitals. In 2009 to 2011, 84%
of newly joining hospitals treated <5 patients per year.
The challenge,
then, is how to transfer DNT best practices from large hospitals to
small hospitals. This knowledge transfer
could occur in the context of professional
conferences, symposia, and webinars. Registries, such as SITS and
GWTG-Stroke,
can facilitate such knowledge exchange among their
member hospitals.
However, not
all best practices at larger volume hospitals will transfer directly to
smaller volume hospitals. Hospital strategies
associated with shorter DNT have been studied, but
not stratified by hospital case volume.4
Smaller hospitals have their own, unique challenges, including fewer
resources, smaller stroke teams, lack of specialists,
absence of trainees, and less case volume with
which to build experience. In many cases, smaller hospitals need to
access
stroke specialist expertise via telestroke. To
facilitate transfer of knowledge of best practices by smaller volume
hospitals,
more research is needed on the distribution of DNT
within these hospitals to see which are consistently capable of giving
tPA quickly. These high performing smaller volume
hospitals could be surveyed to identify their secrets for success, which
could then be disseminated to their peer hospitals.
In addition, more research is needed to identify the factors affecting
DNT in telestroke.
Certification
programs could provide incentives for smaller volume hospitals to
acquire the knowledge and skills to give tPA
rapidly. The American Heart Association/American
Stroke Association-sponsored Target: Stroke program successfully reduced
DNT from 74 minutes in 2009 to 59 minutes in 20135;
given the findings of Strbian et al, it will be important to analyze
whether DNT improvements in Target: Stroke were seen
in all hospitals or were limited to larger
hospitals. The ongoing Reduction of In-hospital Delays in Stroke
Thrombolysis (SITS-WATCH)
study seeks to reduce DNT to <45 minutes in SITS
hospitals (clinicaltrials.gov NCT018119001).
Currently, many large, academic hospitals are focusing their efforts on reducing DNT to the bare minimum.6 The question for these centers is: how low can we go?(Think huge, negative times are possible)7 However, let’s not leave smaller hospitals behind—collectively, they are treating many stroke patients.
No comments:
Post a Comment